Hosted on MSN23d
Stifel defends FTAI Aviation stock after short report, sees upside from key catalystsOn Thursday, Stifel analysts reiterated their Buy rating on FTAI Aviation (NASDAQ:FTAI) stock, with a price target of $167.00. The stock has experienced significant volatility recently ...
Shares of Edgewise Therapeutics (NASDAQ:EWTX) traded flat on Wednesday after Stifel launched its coverage with a Hold recommendation, indicating a balanced risk-reward profile for the muscle drug ...
Stifel Financial Corp. announced a cash dividend of $0.46 per share on its common stock, payable on March 17, 2025, to shareholders recorded by March 3, 2025. Additionally, the company declared ...
Stifel analyst Stephen Gengaro downgraded Canoo (GOEV) to Hold from Buy with a price target of 50c, down from $4.50. The firm cites the company’s need for capital and its recent announcement ...
Stifel has initiated coverage of Cytokinetics (NASDAQ:CYTK) with a buy rating, citing its drug aficamten. The bank noted the stock was "out of favor" in the wake of a "controversial" deal with ...
Stifel analyst Benjamin Nolan upgraded CN (CNI) to Buy from Hold with a lower price target of $120, down from $132, as part of a broader research note previewing Q4 results for Rail companies. The ...
https://www.tipranks.com/news/the-fly/west-bancorporation-price-target-lowered-to-23-from-25-at-piper-sandler Stifel Financial (SF) announced it has signed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results